Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Return on Sales (2016 - 2025)

Iradimed (IRMD) has disclosed Return on Sales for 13 consecutive years, with 0.26% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales fell 1.0% to 0.26% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.25%, a 1.0% decrease, with the full-year FY2024 number at 0.25%, down 1.0% from a year prior.
  • Return on Sales was 0.26% for Q3 2025 at Iradimed, down from 0.28% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.33% in Q4 2021 to a low of 0.15% in Q2 2021.
  • A 5-year average of 0.25% and a median of 0.25% in 2022 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: soared 46bps in 2021, then decreased -8bps in 2022.
  • Iradimed's Return on Sales stood at 0.33% in 2021, then decreased by -23bps to 0.25% in 2022, then rose by 3bps to 0.26% in 2023, then fell by -12bps to 0.23% in 2024, then grew by 15bps to 0.26% in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Return on Sales are 0.26% (Q3 2025), 0.28% (Q2 2025), and 0.24% (Q1 2025).